(Q37800883)

23 August 2017

Aetiology and physiopathology of preeclampsia and related forms (English)

1 reference

23 August 2017

0 references

S Lorquet

1

1 reference

23 August 2017

C Pequeux

series ordinal

2

1 reference

23 August 2017

C Munaut

series ordinal

3

1 reference

23 August 2017

J M Foidart

series ordinal

4

1 reference

23 August 2017

1 July 2010

1 reference

23 August 2017

1 reference

23 August 2017

65

1 reference

23 August 2017

4

1 reference

23 August 2017

237-241

1 reference

Preeclampsia: Diagnosis and management of the atypical presentation

23 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Prediction of maternal predisposition to preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Current topic: pre-eclampsia and the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Latest advances in understanding preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Microparticles and immunomodulation in pregnancy and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Circulating microparticles in normal pregnancy and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Preeclampsia: a renal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Preeclampsia and angiogenic imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Circulating angiogenic factors and preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Glomerular endothelial cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Defective angiogenesis in mice lacking endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Newly developed angiotensin II-infused experimental models in vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

The role of RAS in the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Vitamins C and E and the risks of preeclampsia and perinatal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

The role of antioxidant vitamins in hypertensive disorders of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Preeclampsia: an excessive maternal inflammatory response to pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Levels of dimethylarginines and cytokines in mild and severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Placental stress and pre-eclampsia: a revised view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

Altered global gene expression in first trimester placentas of women destined to develop preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2010.051

21 January 2018

Identifiers

DOI

10.1179/ACB.2010.051

1 reference

23 August 2017

1 reference